Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about PURETECH HEALTH PLC
07/13 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Visit in the Pivotal Gelesis100..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Out in the Pivotal Gelesis100 W..
06/28 PURETECH HEALTH : Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chai..
06/28 PURETECH HEALTH : Former Cubist CEO, DreamWorks Interactive CEO, and Google Chie..
05/30 PURETECH HEALTH : Vedanta Biosciences Granted U.S. Patent Broadly Covering Metho..
05/30 VEDANTA BIOSCIENCES : Granted U.S. Patent Broadly Covering Methods of Treatment ..
05/25 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
05/19 PURETECH HEALTH : Karuna to Present Tolerability Proof-of-Concept Data for KarXT..
05/19 KARUNA PHARMACEUTICALS : to Present KarXT Tolerability Proof-of-Concept Data for..
05/17 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
05/17 PURETECH HEALTH : Sync Project Announces New Investors and Accelerates Developme..
05/16 PURETECH HEALTH : Vedanta Biosciences Granted Three New U.S. Patents for Therape..
05/16 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
05/09 PURETECH HEALTH : Results of Annual General Meeting
More most relevant news
All news about PURETECH HEALTH PLC
07/13 PURETECH HEALTH : Presents Data Supporting Treatment Approach for Interstitial C..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Visit in the Pivotal Gelesis100..
07/12 PURETECH HEALTH : Gelesis Announces Last Patient Out in the Pivotal Gelesis100 W..
06/28 PURETECH HEALTH : Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chai..
06/28 PURETECH HEALTH : Former Cubist CEO, DreamWorks Interactive CEO, and Google Chie..
06/01 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
05/30 PURETECH HEALTH : Vedanta Biosciences Granted U.S. Patent Broadly Covering Metho..
05/30 VEDANTA BIOSCIENCES : Granted U.S. Patent Broadly Covering Methods of Treatment ..
05/25 PURETECH HEALTH : Vedanta Biosciences Granted Three U.S. Patents Broadly Coverin..
05/25 PURETECH HEALTH : to Present at Jefferies 2017 Global Healthcare Conference
More news
Sector news : Biotechnology & Medical Research - NEC
07/26 Autos and energy firms boost European shares as earnings roll in, banks held ..
07/25DJCELGENE : Settles Lawsuit Over Improper Promotion of Cancer Drugs
07/25DJELI LILLY AND : to Delay Arthritis Drug Application -- Market Talk
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/12 FDA panel backs Novartis' pioneering new cancer gene therapy
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
07/13PureTech Health Presents Data Supporting Treatment Approach for Interstitial .. 
07/12PureTech Health : Gelesis Announces Last Patient Visit in the Pivotal Gelesis.. 
07/12Puretech Health PLC's buy rating reiterated at Liberum Capital. GBX 248 PT.  
06/09Puretech Health PLC's buy rating reiterated at Jefferies Group LLC. GBX 255 P.. 
05/25PureTech Health to Present at Jefferies 2017 Global Healthcare Conference  
More tweets
Qtime:6
Financials ($)
Sales 2017 1,85 M
EBIT 2017 -100 M
Net income 2017 -66,8 M
Debt 2017 4,43 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 223x
EV / Sales 2018 207x
Capitalization 408 M
Chart PURETECH HEALTH PLC
Duration : Period :
Puretech Health PLC Technical Analysis Chart | PRTC | GB00BY2Z0H74 | 4-Traders
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 3,13 $
Spread / Average Target 80%
Managers
NameTitle
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, Chief Business & Strategy Officer
Joichi Ito Non-Executive Chairman
Stephen Muniz Chief Operations Officer, Secretary & Director
Michael F. MacLean Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PURETECH HEALTH PLC11.98%408
INCYTE CORPORATION36.82%27 350
QUINTILES IMS HOLDINGS INC19.03%19 536
LONZA GROUP31.41%16 761
CELLTRION, INC.--.--%12 153
ALKERMES PLC4.34%8 884